NanoVibronix files provisional US patent application for UroShield Ultra

NanoVibronix, Inc., a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave technology, today announced it has filed a new provisional patent application with the United States Patent and Trademark Office entitled “Multiple Frequency Surface Acoustic Waves for Internal Medical Device” related to its UroShield.

The Patent Application covers a recently developed enhancement to the UroShield product, UroShield “Ultra”, which incorporates improvements to the Company’s original UroShield. The next generation UroShield Ultra includes modified housing that is designed to improve catheter coupling and incorporates multiple actuators that work in sequence to discourage bacterial docking by delivering SAWs at multiple frequencies directly to indwelling catheters.

“UroShield is, to our knowledge, the only proven, effective solution for the prevention of Catheter Associated Urinary Tract Infections, the single highest source of hospital acquired infections,” stated Brian Murphy, Chief Executive Officer of NanoVibronix. “This new filing expands our portfolio of intellectual property assets and reinforces our competitive position. UroShield has been proven to be instrumental in improving outcomes for hospital patients suffering from CAUTI. We are continually seeking opportunities to improve our products and by employing cutting edge technology.” Business Wire